cDNA clones for the human laminin A chain were isolated from libraries prepared from human gestational choriocarcinoma cell line (JAR) RNA. They cover approx. 8 kb from the 5'-end of the 9.5 kb mRNA coding for this protein. Our clones contain 94 nucleotide residues for the 5'-end untranslated region and 7885 nucleotide residues of coding sequence. The complete human laminin A chain contains a 17-amino acid-residue signal peptide and a 3058-residue A chain proper. The human laminin A chain has a distinct domain structure with numerous internal cysteine-rich repeats. The large globular domain G has five repeats, which have several conserved glycine and cysteine residues. Furthermore the A chain contains 20 internal cysteine-rich repeats present in tandem arrays in three separate clusters (domains IIIa, IIIb and V). Domain I + II has a predicted continuous a-helical structure characterized by heptad repeats and three domains (IVa, lVb and VI) are predicted to contain a number of f-sheets and coiled-coil structures. Northern-blot analysis was used to study the laminin A chain expression in the JAR cell line, full-term placenta and newborn-human tissues (kidney, spleen, lung, heart muscle, psoas muscle and diaphragm muscle). The expression was detectable in newborn-human kidney and JAR cell line only. The overall amino acid sequence identity between human and mouse is 76 %. The human chain has only one Arg-Gly-Asp (RGD) sequence, which is located in the long arm within domain G, whereas the single RGD sequence in the mouse chain is located in the short arm in domain IlIb. The degree of identity between the human laminin A chain sequence and the sequence available for merosin [Ehrig, Leivo, Argraves, Ruoslahti & Engvall (1990) Proc. Natl. Acad. Sci. U.S.A. 87, 3264-3268] is about 41 % and when conservative substitutions are included the degree of similarity is 54 %.
INTRODUCTION
Laminin is a specific component of basement membranes that has been shown to mediate a number of biological functions such as cell adhesion, growth, migration and differentiation [1, 2] . It has been shown to bind to cells through membrane receptors [3] [4] [5] . The laminin molecule is a very complex protein composed of three chains that form a cruciform structure with three short arms and one long arm [2, 6] . The molecule has one heavy (A) chain (Mr approx. 400000) and two light (B) chains (Mr approx. 200000). To date, two related heavy chains have been described, the so called A chain [1, 2] and merosin [7, 8] . Furthermore, there are three types of light chains, B1, B2 [1, 2] and s-laminin [9] . The complete primary structure of the mouse A chain [10] and a part of the human A chain [11] and merosin [8] have been determined. Also, the sequences of the Bi and B2 chains from man [12, 13] , mouse [14, 15] and Drosophila [16, 17] and the s-laminin chain from rat [9] have been reported. All the chains contain globular domains, rod-like domains with cysteine-rich repeats and an azhelical domain that participates in the triple coiled-coil structure forming the long arm of the molecule. Additionally, the A chain has a large C-terminal globule, termed domain G [2, 10, 18] . The existence of multiple laminin component chains enables a variety of molecular compositions whose nature, distribution and biological significance are only beginning to become unravelled. For example, the A chain has been shown to be expressed to a considerably smaller extent in adult mouse tissues than the Bl and B2 chains [19] , and Schwann cells may synthesize a laminin molecule not containing an A chain [20] . Merosin is present in human placenta and Schwann cells [7, 21] . Merosin is not found in the mouse fetus but appears postnatally in muscle and nerve [7, 21] . The Bl and B2 chains are expressed in most tissues that contain basement membranes, but their ratio can vary considerably [22] [23] [24] . Furthermore, the s-laminin chain is primarily found in synaptic basement membranes but is also found in the kidney [9] . A distinct 300000-M, laminin heavy chain in heart muscle has also been described [25] .
Proteolytic-digest fragments, synthetic peptides and domainspecific antibodies have been used to dissect the biologically active regions of the mouse Engelbreth-Holm-Schwarm-tumour laminin molecule and its component chains. These studies have revealed two cell-binding domains, one in the central region of the cross (P1 fragment) and another one in the long arm [2, [26] [27] [28] [29] . It has been suggested that a Tyr-Ile-Gly-Ser-Arg (YIGSR) sequence in domain III in the Bi chain [29] or an Arg-Gly-Asp (RGD)-sequence-containing region in domain IIlb of the A chain [27] is responsible for the cell binding of the P1 fragment. According to Deutzmann et al. [30] , a major cell-binding site is also located in end of the long arm of laminin. Also, fragments from the long arm have been shown to stimulate neural outgrowth [31, 33] , and a heparin-binding domain [34] has been assigned to the globular domain of the A chain. Furthermore laminin fragments from the short arm have been shown to stimulate cell growth [35] , and the A chain may play a role in the polarization of epithelial cells [36] .
Comparison The oligo(dT)-primed JAR cell line cDNA library was screened with the 32P-labelled mouse cDNA clone MamA-1 by using standard protocols [40] . The first primer extension library made with the Cl primer was screened with the longest 32P-labelled clone (A-1) isolated from the JAR cell line cDNA library. The second primer extension library generated with the C2 primer was similarly screened with the longest 32P-labelled clone C1-23 isolated from the first primer extension library. Purified cDNA clones were isolated, subcloned into pUC18/19 plasmids and M13mpl8/19 vectors with standard methods [40] and sequenced from both strands with the dideoxynucleotide chain-termination procedure [41] .
Northern-blot analysis
Human tissue samples were obtained at autopsy from a 6-dayold infant within 6 h after death (provided by Dr. Ritva Herva, University Hospital of Oulu, Oulu, Finland) and immediately frozen in liquid N2. Total RNA was isolated [42] , and about a 20 ,ug sample was electrophoresed in a formaldehyde-containing gel, blotted on to nitrocellulose filters and hybridized with nicktranslated cDNA inserts [40] . As probe for human laminin A chain expression the 2.5 kb A-1 clone (nucleotide residues 5320-7835; see Fig. 2 ) was used. For analysis of Bi chain expression an XbaI-BamHI (2.3 kb) fragment of from the 5'-end of the cDNA sequence (nucleotide residues -180-2157) [12] was used, and for the B2 chain the 2.4 kb HL-205 cDNA containing nucleotide residues 2485-4954 [13] was used.
RESULTS

Isolation and characterization of cDNA clones
Initial screening of several commercial human cDNA libraries from placenta, fibroblasts, endothelium, HT-1080 cells and keratinocytes (Clontech Laboratories, Palo Alto, CA, U.S.A.) that were shown to contain cDNA clones coding for laminin B1 and B2 chains ( [12, 13] ; M. Nissinen, unpublished work) did not yield any positive signals for laminin A chain clones when screened with laminin polyclonal antibodies or with the approx. 2.5 kb mouse AlamAl cDNA clone. However, hybridization of the mouse laminin A chain cDNA clone (AlamAl) to an approx. 9.5 kb mRNA from the human gestational choriocarcinoma cell line JAR (results not shown) indicated significant expression of the laminin A chain gene. This cell has been shown to synthesize significant amounts of laminin containing the A chain [38, 39] .
Therefore an oligo(dT)-primed JAR cell line cDNA library was screened with the mouse cDNA clone, AlamAl. This resulted in the isolation of one 2.5 kb clone, A-1 ( Fig. 1 ), which hybridized with the expected 9.5 kb-size mRNA from the JAR cells (see Fig.   3 ). Initial nucleotide sequencing from both ends of the clone and comparison with the mouse [10] and 3'-end human sequence [11] revealed that the A-1 cDNA coded for the human laminin A chain. The A-1 cDNA clone overlapped 698 bp with the 5'-end of a previously reported [11] (Fig. 1) . The C 1-23 cDNA clone was the longest one, containing an insert of 2.2 kb. A 5'-end sequence of C1-23 was similarly used to prepare the second specific cDNA library as described in the Methods section, and screening of this library with the C1-23 cDNA resulted in the isolation of cDNA clones C2-8, C2-10 and C2-12 ( Fig. 1) . The C2-12 cDNA was 3.6 kb, and it contained sequence coding for the 5'-end untranslated region of the mRNA, the signal peptide and the Nterminal end of the mature laminin A polypeptide chain. Altogether, the clones isolated and characterized in this study spanned 8 .0 kb from the 5'-end of the 9.5 kb mRNA, and thus, together with the previously reported 2.5 kb 3'-end sequence [11] , they provide the coding sequence and primary structure of the entire human laminin A chain.
Nucleotide and amino acid sequences The complete nucleotide sequence of the cDNA clones studied here is shown in Fig. 2 . together with the deduced amino acid sequence. The previously reported [11] 680-residue C-terminal amino acid sequence (residues 2379-3058; Fig. 2 ) is also shown to provide here the complete sequence of the A chain. Differences in the amino acid sequence between the human and mouse A chains are also indicated. The sequence of the overlapping cDNA clones characterized in this study contains 95 nucleotide residues coding for the 5'-end untranslated region and 7885 nucleotide residues of open reading frame. There is a putative 17-residue signal peptide composed of the translation initiator methionine residue followed by a typical hydrophobic leucinerich sequence that contains two cysteine residues. The signal peptide of the mouse chain is 24 residues in length and contains no cysteine residues. The N-terminal end of the mature mouse A chain, determined by amino acid sequencing [43] , starts with a glutamine residue whereas the equivalent residue in the human chain is arginine.
The mature human A chain mRNA encodes 3058 amino acid residues, two less than the mouse counterpart. The A chain has a distinct domain structure with numerous internal cysteine-rich repeats, as has been described for the mouse A chain [10] . There is a large domain G of 950 residues (residues 2109-3058) at the C-terminal end (Fig. 1) . The aligned amino acid sequence of the human and mouse A chains (Fig. 2) shows The overall degree of amino acid sequence identity between the human and mouse chains was calculated to be 76 %. All 164 cysteine residues with the exception of one (2561) are conserved between the two species. Also, 23 out of 30 potential attachment sites for asparagine-linked oligosaccharides in the human chain are conserved in the mouse. Interestingly, the human chain has only one RGD sequence, which is located in the long arm within domain G (residues 2517-2519), whereas the single RGD sequence in the mouse chain [10] Norther-blot analysis of human newborn tissues hybridized with human laninin A-chain, Bl-chain and B2-chain cDNA probes Nitrocellulose filters containing size-fractionated total RNA (20 ,ug) were prepared and hybridized as described in the Methods section. Lane strong signal with the A-chain probe on 9.5 kb mRNA from the JAR cells, whereas no signal was apparent even after a long exposure in the human tissues with the exception of kidney (Fig.  3) . In contrast, the B1-chain probe gave strong signals with RNA from kidney, lung, heart muscle and placenta, whereas the signals were considerably weaker for JAR cell, liver, spleen, diaphragm muscle and psoas muscle RNA. The signal pattern with the B2-chain probe was similar to that of the B1-chain probe except that RNA from JAR cells and diaphragm muscle gave somewhat more intense signals.
DISCUSSION
The present work, together with a previously reported 680-residue C-terminal sequence [11] , provides the entire primary structure of the 3058-residue mature human laminin A chain, together with a 17-residue putative signal peptide sequence. Comparison with the 3060-residue mouse sequence [10] revealed a high degree of similarity between the two species. There is a 76% sequence identity at the amino acid level for the mature chains, and when conservative substitutions are included the degree of similarity is 83.7 %. This degree of sequence identity is considerably less than has been noted for the B chains: for example, human and mouse B1 chains share 93 % identity at the amino acid level [12] . The conserved sequences includes 163 of 164 cysteine residues and 23 of the 30 potential attachment sites for asparagine-linked oligosaccharides present in the human chain.
The RGD triplet sequence has been shown to be involved in cell binding to several proteins such as fibronectin, vitronectin and collagens [44] . One such RGD sequence has been found located in the short arm within domain IIIb (residues 1123-1125) in the mouse laminin A chain [10] . Aumailley et al. [27] have reported that this region of the mouse A chain contains cellbinding activity that possibly involves the RGD sequence.
However, the present study shows that the human laminin A chain does not contain an RGD (Arg-Gly-Asp) sequence in domain IlIb or any region nearby. Instead the human chain contains the sequence Arg-Ala-Asp at this position (residues 1123-1125). The human A chain does, however, contain one Arg-Gly-Asp sequence, but in domain G (residues 2517-2519), the large globular domain at the end of the long arm. The mouse A chain has the sequence Ala-Gly-Gly at this location (see Fig.  2 and ref. [10] ), and in addition the human merosin chain exhibits no apparent RGD-related sequence at this or any other location in its G domain (see Fig. 4 and ref. [8] ). The lack of conservation of the positions of the sole RGD sequences found in the human and mouse A chains together with the absence of such a sequence from the G-domain of human merosin in comparison with the human A chain suggests that the described RGD motifs may have arisen merely by chance and have no true biological significance. Further experiments are required to determine activities of these A chain motifs in terms of specific cell-binding.
It was of interest to compare the human laminin A chain sequence elucidated in the present study with the sequence available for human merosin, which has been shown to be similar to the laminin A chain [8] . Indeed, alignment of the two sequences (Fig. 4) demonstrates that the two proteins are closely related.
The published 1130-residue merosin sequence could be easily aligned with sequence (residues 1937-3044) from the C-terminal end of the laminin A chain. The aligned sequence involved the Cterminal region (172 residues) of domain I + II of the A chain and the entire 950-residue domain G with the exception of the 14 last residues. The comparison of sequences from domain G showed that 12 out of 15 cysteine residues are conserved in the two chains in this region. A total of 414 residues were identical in this part of domain G, giving 42.5 % sequence identity. Additionally there are 133 residues that represent conservative amino acid substitutions, and when they are included the total degree of sequence similarity between merosin and domain G of the A chain is 56 %. It may be noted that the RGD sequence in domain G of the human A chain is not conserved in the human merosin chain (see Fig. 4 ). The alignment of a 172-residue sequence from domain I + II of the A chain (residues 1937-2108) with the comparable merosin sequence (173 residues) also showed a considerable degree of similarity, with 32% sequence identity and 44 % sequence similarity when conservative substitutions are included. The overall sequence identity between merosin and A chain is about 41 %, and when conservative substitutions are included the degree of similarity is about 54 %. Consequently the merosin chain appears to be a variant of the laminin A chain, and is an integral component of the laminin molecule in certain tissues where it substitutes for the A chain.
It has become apparent that the laminin molecule exists in a variety of isoforms composed of at least five different subunit chains. The present study confirms previous data [19] [20] [21] [22] [23] [24] of development is as yet poorly understood. With regard to the A chain, the present study has demonstrated negligible expression of the A chain as compared with expression of the Bl and B2 chains in all human tissues studied. In fact, in the eight human tissues studied, we could detect expression of the A chain only in the kidney, although even in this tissue its expression was considerably lower than that of the B I and B2 chains with the use of same-size cDNA probes with similar specific activities. It would be of interest to explore the expression of the meresin chain in the same tissues. Leivo & Engvall [7] have shown that merosin is not expressed in the mouse embryo, and after birth it is expressed only in muscle and nerves. Therefore it seems.likely that in tissues other than muscle and nerves laminin molecules contain as yet unidentified variant(s) of the A chain. Another possibility is that some laminin molecules are completely devoid of a heavy (A) chain. Considering the fact that the A chain and merosin are variants of alternatively used laminin heavy chains and that other heavy laminin chains may exist [25] , it would be appropriate for reasons of clarity to refer to the heavy chains collectively as A chains. Thus the 'classical' A chain could be referred to as Al, merosin as A2 and other potential A chains in a similar fashion. In addition it would be sensible to term variants of the laminin light (B) chains B1, B2 and B3 (s-laminin).
